Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers

M. Chatzinikolaidou, T. K. Lichtinger, R. T. Müller, H. P. Jennissen

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)


Recombinant human BMP-2 (rhBMP-2) was immobilized non-covalently and covalently as a monolayer on plasma vapour deposited (PVD) porous commercially pure titanium surfaces in amounts of 5-8 μg cm-2, providing a ca. 10-fold increase vs. previously reported values [37]. Dissociation of the immobilized [125I]rhBMP-2 from the surface occurred in a two-phase exponential decay: a first rapid phase (ca. 15% of immobilized BMP-2) with a half-life of 1-2 days and a second slow sustained release phase (ca. 85% of immobilized BMP-2) with a half-life of 40-60 days. Dissociation rate constants of sustained release of k-1 = 1.3-1.9 × 10-7 s -1 were determined, allowing an estimation of the binding constants (KA) for the adsorbed rhBMP-2 monolayer, to be around 1012 M-1. The rhBMP-2-coated surfaces showed a high level of biological activity, as demonstrated by in vitro epifluorescence tests for alkaline phosphatase with MC3T3-E1 cells and in vivo experiments. In vivo osteoinductivity of rhBMP-2-coated implants was investigated in a gap-healing model in the trabecular bone of the distal femur condylus of sheep. Healing occurred without inflammation or capsule formation. The calculated concentration of released rhBMP-2 in the 1 mm gap ranged from 20 to 98 nM - well above the half-maximal response concentration (K0.5) for inducing alkaline phosphatase in MC3T3-E1 cells. After 4, 9 and 12 weeks the bone density (BD) and bone-to-implant contact (BIC) of the explanted implants were assessed histomorphometrically. Implants with immobilized rhBMP-2 displayed a significant (2- to 4-fold) increase in BD and BIC values vs. negative controls after 4-9 weeks. Integration of implants by trabecular bone was achieved after 4 weeks, indicating a mean "gap-filling rate" of ∼250 μm week -1. Integration of implants by cortical bone was observed after 9 weeks. Control implants without rhBMP-2 were not osseointegrated. This study demonstrates the feasibility of enhancing peri-implant osseointegration and gap bridging by immobilized rhBMP-2 on implant surfaces which may serve as a model for future clinical applications.

Original languageEnglish
Pages (from-to)4405-4421
Number of pages17
JournalActa Biomaterialia
Issue number11
Publication statusPublished - Nov 2010
Externally publishedYes


  • Functionalized nanostructured titanium
  • Immobilized BMP-2 binding constants
  • Immobilized BMP-2 rate constants
  • Osseointegration in ovine model
  • Peri-implant bone induction

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology

Fingerprint Dive into the research topics of 'Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers'. Together they form a unique fingerprint.

Cite this